Study in Healthy Males to Assess Distribution, Metabolism, and Excretion of Radio-labelled AZD9742 Administered as a 2-hour Infusion

Withdrawn before enrolling · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to assess distribution, metabolism, and excretion of radio-labelled AZD9742 administered as a 2-hour infusion to healthy male volunteers.

Key facts

Study ID
NCT01275781
Run by
AstraZeneca
People needed
0
Starts
2011-01-01
Expected to finish
2011-02-01
Last updated by the study team
2013-01-29

Who can join

Age: 55 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.